More significantly, we propose intranasal administration of BDNF or antagomir-miR-10a-5p as an innovative and practical treatment strategy for PPD, combining efficacy with ease of application. This evidence concerns the gene BDNF and progressive pseudorheumatoid arthropathy of childhood.